Roystone Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-331,274
Closed -$40.8M 47
2017
Q1
$40.8M Sell
331,274
-162,960
-33% -$19.3M 2.64% 17
2016
Q4
$54.5M Sell
494,234
-185,309
-27% -$20.6M 3.22% 15
2016
Q3
$80.3M Buy
679,543
+243,509
+56% +$28.7M 4.88% 3
2016
Q2
$48.8M Buy
436,034
+63,554
+17% +$6.84M 3.07% 15
2016
Q1
$37.5M Buy
+372,480
New +$35.7M 2.61% 17
2015
Q1
Sell
-634,962
Closed -$58.9M 38
2014
Q4
$58.9M Buy
+634,962
New +$56.1M 2.33% 22

Other funds holding LH

Roystone Capital Management's LH Position: Q2 2017 in Review

Roystone Capital Management sold out of Labcorp (LH) in Q2 2017, closing a stake of 331,274 shares — an estimated $40.8M sold.

Roystone Capital Management first reported a position in LH in Q4 2014 and held it in 6 quarters. The position peaked at $80.3M in Q3 2016. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Roystone Capital Management reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
  • Roystone Capital Management sold 331,274 Labcorp shares in Q2 2017, an estimated $40.8M.
  • Roystone Capital Management first reported a position in Labcorp in Q4 2014 and held it in 6 quarters.
  • Roystone Capital Management's Labcorp position peaked at $80.3M in Q3 2016.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Roystone Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.